SE8602917L - Furosemidsalter - Google Patents

Furosemidsalter

Info

Publication number
SE8602917L
SE8602917L SE8602917A SE8602917A SE8602917L SE 8602917 L SE8602917 L SE 8602917L SE 8602917 A SE8602917 A SE 8602917A SE 8602917 A SE8602917 A SE 8602917A SE 8602917 L SE8602917 L SE 8602917L
Authority
SE
Sweden
Prior art keywords
dosage forms
furosemide
bioavailable
affording
burden
Prior art date
Application number
SE8602917A
Other languages
English (en)
Swedish (sv)
Other versions
SE8602917D0 (sv
Inventor
L Chafetz
J Philip
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SE8602917D0 publication Critical patent/SE8602917D0/xx
Publication of SE8602917L publication Critical patent/SE8602917L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
SE8602917A 1985-07-02 1986-07-01 Furosemidsalter SE8602917L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/751,763 US4663348A (en) 1985-07-02 1985-07-02 Furosemide salts and pharmaceutical preparations thereof

Publications (2)

Publication Number Publication Date
SE8602917D0 SE8602917D0 (sv) 1986-07-01
SE8602917L true SE8602917L (sv) 1987-01-03

Family

ID=25023379

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602917A SE8602917L (sv) 1985-07-02 1986-07-01 Furosemidsalter

Country Status (14)

Country Link
US (1) US4663348A (enExample)
JP (1) JPS625975A (enExample)
AU (1) AU599034B2 (enExample)
BE (1) BE904986A (enExample)
CH (1) CH670448A5 (enExample)
DE (1) DE3619665A1 (enExample)
DK (1) DK312586A (enExample)
FR (1) FR2584405B1 (enExample)
GB (1) GB2189239B (enExample)
IT (1) IT1191972B (enExample)
LU (1) LU86484A1 (enExample)
NL (1) NL8601519A (enExample)
SE (1) SE8602917L (enExample)
ZA (1) ZA864207B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920145A (en) * 1988-02-29 1990-04-24 Gaf Chemical Corporation Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof
IT1237115B (it) * 1989-10-24 1993-05-18 Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono
WO1993010983A1 (en) * 1991-12-03 1993-06-10 Kokuyo Kabushiki Kaisha Filing device openable/closable on both sides
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
RU2416404C1 (ru) * 2009-10-05 2011-04-20 Государственное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Средство, обладающее мочегонным действием
EP2535342B1 (en) * 2010-02-10 2014-08-06 Kissei Pharmaceutical Co., Ltd. Salt of fused heterocyclic derivative and crystal thereof
CN105431145B (zh) 2013-04-05 2019-12-10 Sc医药品有限公司 用于呋塞米的皮下施用的药物制剂
ES3041602T3 (en) 2018-12-10 2025-11-13 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof
ES3058386T3 (es) 2019-01-04 2026-03-10 Sq Innovation Ag Composiciones farmacéuticas de furosemida
EP3906020B1 (en) 2019-01-04 2025-12-31 SQ Innovation AG Pharmaceutical compositions of torsemide and their uses
AU2020214314B2 (en) 2019-01-31 2025-09-18 Scpharmaceuticals Inc. Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
DK138322B (da) * 1970-07-13 1978-08-14 Dumex Ltd As Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater.
FR2210607A1 (en) * 1972-12-20 1974-07-12 Aries Robert 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
LU74319A1 (enExample) * 1976-02-09 1977-08-19
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung

Also Published As

Publication number Publication date
JPS625975A (ja) 1987-01-12
FR2584405B1 (fr) 1989-02-24
DE3619665A1 (de) 1987-01-08
FR2584405A1 (fr) 1987-01-09
LU86484A1 (fr) 1986-12-02
DK312586D0 (da) 1986-07-01
AU599034B2 (en) 1990-07-12
CH670448A5 (enExample) 1989-06-15
AU5889086A (en) 1987-01-08
IT8648183A0 (it) 1986-06-25
GB2189239B (en) 1989-02-01
NL8601519A (nl) 1987-02-02
IT8648183A1 (it) 1987-12-25
IT1191972B (it) 1988-03-31
GB8615275D0 (en) 1986-07-30
US4663348A (en) 1987-05-05
ZA864207B (en) 1987-02-25
DK312586A (da) 1987-01-03
BE904986A (fr) 1986-12-24
SE8602917D0 (sv) 1986-07-01
GB2189239A (en) 1987-10-21

Similar Documents

Publication Publication Date Title
SE8602917D0 (sv) Furosemidsalter
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DK162986D0 (da) Terapeutisk middel i enhedsdosisform
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
DE3684121D1 (de) Pharmazeutische zusammensetzung vom fluessig/gel-phasenuebergangstyp.
GR76810B (enExample)
ATE87471T1 (de) Eine fluessige verabreichungsform fuer orale verabreichung einer pharmazeutischen substanz.
NO863029D0 (no) Farmasoeytisk doseringsenhet.
SE8402098D0 (sv) Perfluorkarbonemulsion, framstellning derav samt dess anvendning i terapi
IT8223147A0 (it) Preparato farmaceutico equilibrato idrodinamicamente dotato di cessione protratta della sostanza attiva.
DE68909409D1 (de) Heilmitteldosierung zur verabreichung an fische.
DE3482768D1 (de) Kontrastmittel und deren verwendung.
EA200200151A1 (ru) Сухая порошкообразная композиция
SE8303003L (sv) Medel for att oka antitumorverkan hos antitumormedel
DK23386A (da) Pyridopyrimidiner, deres fremstilling og anvendelse som laegemidler
NO863625D0 (no) Medikamentdoseringsanordning.
MX9203782A (es) Forma de dosis con capacidad de administracion mejorada.
ES2052670T3 (es) Utilizacion de derivados de 2-pirimidinil-1-piperazina.
ES548988A0 (es) Procedimiento de solubilizacion,en el momento del empleo,de un principio activo lipofilo en una solucion acuosa,con ob- jeto de su administracion por via intravenosa
NL188891C (nl) Farmaceutisch preparaat met bloeddrukverlagende werking dat co-dergocrine en nog een actief materiaal bevat.
DK528386A (da) Proteinabsorptionsforoegende midler
IT1170342B (it) Agente farmaceutico per il trattamento di tumori in fase di metastatizzazione e di anemie da labilita' della membrana eritrocitaria
KR880002521A (ko) 약제 제형
郑伯承 ZHANG ZHONGJING, THE SAGE OF CHINESE MEDICINE
IT8619249A0 (it) Kit per la determinazione dell'attivita' proliferativa nei tumori umani.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8602917-0

Effective date: 19920201